Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435-Reference-Cited by-同舟云学术

Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435

Published:1981-01 Issue:1 Volume:23 Page:63-75
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Pekka Lähteenmäki,Erik Weiner,Pertti Lähteenmäki,Elof Johansson,Tapani Luukkainen

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference28 articles.

1. Single administration of hormones for long-term control of reproductive function;Segal,1967

2. Contraception with subdermal implants containing gestagens. Plasma levels of d-norgestrel and megestrol acetate and effects on the ovarian steroid pattern;Weiner,1976

3. One-year contraception with norgestrienone subdermal silastic implants;Coutinho;Fertil Steril,1974

4. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone;Da Silva;Int J Fertil,1978

5. Long-acting contraceptive implants. An analysis of menstrual bleeding patterns;Faundes;Contraception,1978

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in the cerebroprotection by Nestorone intranasal delivery following stroke in mice;Neuropharmacology;2021-10

2. Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception;Pharmacology & Therapeutics;2021-06

3. Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men;Andrology;2019-04-10

4. A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women;Contraception;2015-10

5. Emerging female contraceptives;Expert Opinion on Emerging Drugs;2011-01-17